Selective cytostatic and neurotoxic effects of avermectins and activation of the GABA(α) receptors

Bioscience Reports

Volumn 19, Issue 6, 1999, Pages 535-546

  Kokoz, Yuri M ^a   Tsyganova, Vera G ^a   Korystova, Antonina F ^a   Grichenko, Alexey S ^a   Zenchenko, Konstantin I ^a   Drinyaev, Victor A ^b   Mosin, Vladimir A ^b   Kruglyak, Elena B ^b   Sterlina, Tatyana S ^b   Victorov, Alexander V ^b  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^b NBC Pharmbiomed   (Russian Federation)

Author keywords

Avermectins; Bicuculline; Cytotoxicity; GABA( ) receptors; Nembutal; Neuroblastoma B103; Picrotoxin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AVERMECTIN DERIVATIVE; BICUCULLINE; PENTOBARBITAL; PICROTOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL GROWTH; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MALE; NEUROTOXICITY; NONHUMAN; RAT;

EID: 0033505369     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020262811459     Document Type: Article

References (29)

1. 1. Campbell, W. C. (ed.), Ivermectin and Abamectin (1989) Springer-Verlag, New York.
2. 2. Equerton, J. R. et al. (1979) Antimicrob. Agents Chemother. 15:372-378.
3. 3. Hotson, I. K. (1982) J. S. Afr. Vet. Assoc. 53:87-90.
4. 4. Duce, I. R., and Scott, R. H. (1983) J. Physiol. 343:32P.
5. 5. Duce, I. R., and Scott, R. H. (1985) Brit. J. Pharmacol. 85:395-401.
6. 6. Bokisch, A. J., and Walker, R. J. (1986) Comp. Biochem. Physiol. C. 84:119-125.
7. 7. Arena, J. P., Liu, K. K., Paress, P. S., Schaeffer, J. M., and Cully, D. F. (1992) Mol. Brain Res. 15: 339-348.
8. 8. Cully, D. F. et al. (1994) Nature 371:707-711.
9. 9. Arena, J. P. et al. (1995) J. Parasitol. 81:286-294.
10. 10. Cully, D. F., Paress, P. S., Liu, K. K., Schaeffer, J. M., and Arena, J. P. (1996) J. Biol. Chem. 271:20187-20191.
11. 11. Vassilatis, D. K. et al. (1997) J. Mol Evol. 44:501-508.
12. 12. Mellin, T. N., Busch, R. D., and Wang, C. C. (1983) Neuropharm. 22:89-96.
13. 13. Martin, R., and Pennington, A. J. (1988) Neurotox. 88:Abstr. 141.
14. 14. Abalis, I. M., Eldefrawi, A. T., and Eldefrawi, M. E. (1986) J. Blochem. Toxicol 1:69-82.
15. 15. Pong, S. S., DeHaven, R., and Wang, C. C. (1982) J. Neurosci. 2:966-971.
16. 16. Soderlund, D. M., Adams, P. M., and Bloomquist, J. R. (1987) Biochem. Biophys. Res. Commun. 146:692-698.
17. 17. Bloomquist, J. R., Grubs, R. E., Soderlund, D. M., and Knipple, D. C. (1991) Comp. Biochem. Physiol. C 99:397-402.
18. 18. Huang, J., and Casida, J. E. (1997) J. Pharmacol Exp. Ther. 281:261-266.
19. 19. Eldefrawi, A. T., and Eldefrawi, M. E. (1987) FASEB J 1:262-271.
20. 20. Payne, G. T., and Soderlund, D. M. (1991) J. Biochem. Toxicol. 6:283-292.
21. 21. Schunrock, B., and Bormann, J. (1993) Naunyn Schmiedebergs Arch. Pharmacol. 348:628-632.
22. 22. Drinyaev, V. A. et al. (1999) Applied Biochem. Microbiol. (Russian) 35:206-212.
23. 23. Korystov, Yu. N. et al. (1999) Acta Veterinaria Brno, accepted for publication.
24. 24. Schubert, D. et al. (1974) Nature 249:224-227.
25. 25. Schubert, D., Carlisle, W., and Look, C. (1975) Nature 254:341-343.
26. 26. Lankas, G. R., Cartwright, M. E., and Umbenhauer, D. (1997) Toxicol. Appl. Pharmacol. 143:357-365.
27. 27. Lautier, R., Canitrot, Y., Deeley, R. G., and Cole, S. P. (1996) Biochem. Pharmacol. 52:967-977.
28. 28. Van der Heyden, S., Gheuens, E., Debruijn, E., Van Oosterom, A., and Maes, R. (1995) Crit. Rev. Clin. Lab. Sci. 32:221-264.
29. 29. Pouliot, J K., L'Heureux, F., Liu, Z., Prichard, R. K., and Georgeas, E. (1997) Biochem. Pharmacol. 53:17-25.